BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33549103)

  • 21. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
    Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
    J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Epstein-Barr virus causes epithelial-mesenchymal transition in human corneal epithelial cells via Syk/src and Akt/Erk signaling pathways.
    Park GB; Kim D; Kim YS; Kim S; Lee HK; Yang JW; Hur DY
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1770-9. PubMed ID: 24569586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.
    Navari M; Fuligni F; Laginestra MA; Etebari M; Ambrosio MR; Sapienza MR; Rossi M; De Falco G; Gibellini D; Tripodo C; Pileri SA; Leoncini L; Piccaluga PP
    Front Microbiol; 2014; 5():728. PubMed ID: 25566237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanisms of Epstein-Barr Virus-Mediated Oncogenesis].
    Iwakiri D
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1133-6. PubMed ID: 26489540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
    Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
    Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
    Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
    mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients' survival.
    Huang YC; Lin SJ; Lin KM; Chou YC; Lin CW; Yu SC; Chen CL; Shen TL; Chen CK; Lu J; Chen MR; Tsai CH
    Blood; 2016 Sep; 128(12):1578-89. PubMed ID: 27338098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine Development for Epstein-Barr Virus.
    Cohen JI
    Adv Exp Med Biol; 2018; 1045():477-493. PubMed ID: 29896681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D
    N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders.
    Crombie JL; LaCasce AS
    Front Oncol; 2019; 9():109. PubMed ID: 30899698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
    Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation.
    Iwakiri D; Takada K
    J Immunol; 2004 Feb; 172(3):1561-6. PubMed ID: 14734735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.
    Geng L; Wang X
    Int J Clin Exp Med; 2015; 8(9):14656-71. PubMed ID: 26628948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNAs involvement in Epstein-Barr virus infection and tumorigenesis.
    Zhang J; Li X; Hu J; Cao P; Yan Q; Zhang S; Dang W; Lu J
    Virol J; 2020 Apr; 17(1):51. PubMed ID: 32272952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas.
    Nepomuceno RR; Balatoni CE; Natkunam Y; Snow AL; Krams SM; Martinez OM
    Cancer Res; 2003 Aug; 63(15):4472-80. PubMed ID: 12907620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
    Hui KF; Tam KP; Chiang AKS
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29160853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
    Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
    Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.